Want to join the conversation?
For 2016, $ROP expects adjusted DEPS to be in the range of $6.57-6.71 and 3Q16 adjusted DEPS to be between $1.59-1.63. The company expects 2H16 revenue to increase between 7-9%, including organic growth of 2-4%. The company stated that the above guidance metrics excludes the impact of any future acquisitions or divestitures.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?